10-Q Filing

Niagen Bioscience, Inc. CIK: 1386570 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001654954-17-007224`
Period End Date	20170630
Filing Date	20170810
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	cdxc-20170701.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 81 Cash Flow Statement 74 Stockholders Equity 21

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts and returns	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.08M	USD	Point-in-time
Allowance for doubtful accounts and returns	`AllowanceForDoubtfulAccountsReceivableCurrent`	$736.00K	USD	Point-in-time
Common Stock, Par Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$3.37M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Cash	`Cash`	$1.64M	USD	Point-in-time
Cash	`Cash`	$14.14M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	45.57M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	37.54M	shares	Point-in-time
Trade receivables, net of allowances of $736,000 and $1,081,000, respectively	`AccountsReceivableNetCurrent`	$5.85M	USD	Point-in-time
Trade receivables, net of allowances of $736,000 and $1,081,000, respectively	`AccountsReceivableNetCurrent`	$4.58M	USD	Point-in-time
Inventories	`InventoryNet`	$7.79M	USD	Point-in-time
Inventories	`InventoryNet`	$7.91M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	45.57M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	37.54M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$329.85K	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$864.93K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.38M	USD	Point-in-time
Leasehold Improvements and Equipment, net	`PropertyPlantAndEquipmentNet`	$3.37M	USD	Point-in-time
Leasehold Improvements and Equipment, net	`PropertyPlantAndEquipmentNet`	$3.11M	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$397.21K	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$402.50K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.77M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$486.23K	USD	Point-in-time
Longterm investment	`LongTermInvestments`	-	USD	Point-in-time
Longterm investment	`LongTermInvestments`	$20.32K	USD	Point-in-time
Total assets	`Assets`	$32.92M	USD	Point-in-time
Total assets	`Assets`	$19.75M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.13M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.98M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.17M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$2.11M	USD	Point-in-time
Current maturities of capital lease obligations	`CapitalLeaseObligationsCurrent`	$299.10K	USD	Point-in-time
Current maturities of capital lease obligations	`CapitalLeaseObligationsCurrent`	$255.46K	USD	Point-in-time
Customer deposits and other	`CustomerAdvancesAndDeposits`	$389.01K	USD	Point-in-time
Customer deposits and other	`CustomerAdvancesAndDeposits`	$503.85K	USD	Point-in-time
Deferred rent, current	`DeferredRentCreditCurrent`	$76.22K	USD	Point-in-time
Deferred rent, current	`DeferredRentCreditCurrent`	$114.10K	USD	Point-in-time
Due to officer	`EmployeeRelatedLiabilitiesCurrent`	$100.00K	USD	Point-in-time
Due to officer	`EmployeeRelatedLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.26M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$8.87M	USD	Point-in-time
Capital lease obligations, less current maturities	`CapitalLeaseObligationsNoncurrent`	$343.59K	USD	Point-in-time
Capital lease obligations, less current maturities	`CapitalLeaseObligationsNoncurrent`	$393.18K	USD	Point-in-time
Deferred rent, less current	`DeferredRentCreditNoncurrent`	$547.54K	USD	Point-in-time
Deferred rent, less current	`DeferredRentCreditNoncurrent`	$564.97K	USD	Point-in-time
Total Liabilities	`Liabilities`	$7.20M	USD	Point-in-time
Total Liabilities	`Liabilities`	$9.78M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $.001 par value; authorized 150,000,000 shares; issued and outstanding July 1, 2017 45,571,891 shares and December 31, 2016 37,544,531 shares	`CommonStockValue`	$45.57K	USD	Point-in-time
Common stock, $.001 par value; authorized 150,000,000 shares; issued and outstanding July 1, 2017 45,571,891 shares and December 31, 2016 37,544,531 shares	`CommonStockValue`	$37.55K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$55.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$75.59M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-49.92M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-45.22M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.37M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$25.72M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.97M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$32.92M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.75M	USD	Point-in-time

Income Statement 81 line items

Line Item	Tag	Value	Unit	Period
Sales, net	`SalesRevenueGoodsNet`	$16.16M	USD	2 Qtrs
Sales, net	`SalesRevenueGoodsNet`	$8.83M	USD	1 Quarter
Sales, net	`SalesRevenueGoodsNet`	$5.31M	USD	1 Quarter
Sales, net	`SalesRevenueGoodsNet`	$9.76M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$4.70M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$5.74M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$8.58M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$3.04M	USD	1 Quarter
Gross profit	`GrossProfit`	$4.02M	USD	2 Qtrs
Gross profit	`GrossProfit`	$4.13M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.26M	USD	1 Quarter
Gross profit	`GrossProfit`	$7.58M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$1.32M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$728.30K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$698.03K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$1.24M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.22M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.51M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$849.96K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$751.73K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.66M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.04M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.31M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.30M	USD	2 Qtrs
Other	`OtherExpenses`	$745.77K	USD	1 Quarter
Other	`OtherExpenses`	$745.77K	USD	2 Qtrs
Other	`OtherExpenses`	-	USD	2 Qtrs
Other	`OtherExpenses`	-	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.63M	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$6.75M	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$4.98M	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$3.76M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-2.72M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$825.20K	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-4.61M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$371.13K	USD	1 Quarter
Interest expense, net	`InterestExpense`	$332.49K	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$45.29K	USD	1 Quarter
Interest expense, net	`InterestExpense`	$83.20K	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$144.79K	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-313.10K	USD	1 Quarter
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-313.10K	USD	2 Qtrs
Nonoperating expenses	`NonoperatingIncomeExpense`	$-457.88K	USD	1 Quarter
Nonoperating expenses	`NonoperatingIncomeExpense`	$-83.20K	USD	2 Qtrs
Nonoperating expenses	`NonoperatingIncomeExpense`	$-45.29K	USD	1 Quarter
Nonoperating expenses	`NonoperatingIncomeExpense`	$-645.59K	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.76M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$179.61K	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-86.75K	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.69M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$-4.09K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$6.65K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$172.96K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.93M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-82.67K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-2.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Basic earnings (loss) per common share	`EarningsPerShareBasic`	-	USD	2 Qtrs
Basic earnings (loss) per common share	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic earnings (loss) per common share	`EarningsPerShareBasic`	$-0.12	USD	2 Qtrs
Basic earnings (loss) per common share	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Diluted earnings (loss) per common share	`EarningsPerShareDiluted`	$-0.12	USD	2 Qtrs
Diluted earnings (loss) per common share	`EarningsPerShareDiluted`	-	USD	2 Qtrs
Diluted earnings (loss) per common share	`EarningsPerShareDiluted`	$-0.07	USD	1 Quarter
Diluted earnings (loss) per common share	`EarningsPerShareDiluted`	-	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic weighted average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	42.12M	shares	1 Quarter
Basic weighted average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	36.99M	shares	1 Quarter
Basic weighted average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	40.08M	shares	2 Qtrs
Basic weighted average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	36.70M	shares	2 Qtrs
Diluted weighted average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	42.12M	shares	1 Quarter
Diluted weighted average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.47M	shares	2 Qtrs
Diluted weighted average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	36.99M	shares	1 Quarter
Diluted weighted average common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	40.08M	shares	2 Qtrs
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	36.99M	shares	1 Quarter
Basic and diluted weighted average common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	42.12M	shares	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$172.96K	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.93M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-82.67K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-2.76M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Depreciation of leasehold improvements and equipment	`Depreciation`	$264.24K	USD	2 Qtrs
Depreciation of leasehold improvements and equipment	`Depreciation`	$159.37K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$38.41K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$89.80K	USD	2 Qtrs
Share-based compensation expense	`AllocatedShareBasedCompensationExpense`	$657.64K	USD	2 Qtrs
Share-based compensation expense	`AllocatedShareBasedCompensationExpense`	$719.69K	USD	2 Qtrs
Allowance for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$29.65K	USD	2 Qtrs
Allowance for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$-344.06K	USD	2 Qtrs
Loss from disposal of equipment	`GainLossOnDispositionOfAssets`	-	USD	2 Qtrs
Loss from disposal of equipment	`GainLossOnDispositionOfAssets`	$1.45K	USD	2 Qtrs
Non-cash loss on debt extinguishment	`GainLossOnNonRecourseDebt`	-	USD	2 Qtrs
Non-cash loss on debt extinguishment	`GainLossOnNonRecourseDebt`	$-32.01K	USD	2 Qtrs
Non-cash financing costs	`NoncashFinancingCosts`	$56.59K	USD	2 Qtrs
Non-cash financing costs	`NoncashFinancingCosts`	$94.08K	USD	2 Qtrs
Trade receivables	`IncreaseDecreaseInReceivables`	$1.63M	USD	2 Qtrs
Trade receivables	`IncreaseDecreaseInReceivables`	$-4.37M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$179.36K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$3.63M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-266.83K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-554.68K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.95M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.89M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-62.17K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$634.56K	USD	2 Qtrs
Customer deposits and other	`IncreaseDecreaseInCustomerDeposits`	$-9.15K	USD	2 Qtrs
Customer deposits and other	`IncreaseDecreaseInCustomerDeposits`	$114.84K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInOtherDeferredLiability`	$106.66K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInOtherDeferredLiability`	$20.45K	USD	2 Qtrs
Due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$-32.50K	USD	2 Qtrs
Due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.99M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.56M	USD	2 Qtrs
Purchases of leasehold improvements and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$295.08K	USD	2 Qtrs
Purchases of leasehold improvements and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$231.20K	USD	2 Qtrs
Purchases of intangible assets	`PaymentsToAcquireIntangibleAssets`	$183.96K	USD	2 Qtrs
Purchases of intangible assets	`PaymentsToAcquireIntangibleAssets`	$195.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-479.04K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-426.20K	USD	2 Qtrs
Proceeds from issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$5.72M	USD	2 Qtrs
Proceeds from issuance of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$18.71M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$622.38K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$11.97K	USD	2 Qtrs
Payment of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Payment of debt issuance cost	`PaymentsOfDebtIssuanceCosts`	$42.28K	USD	2 Qtrs
Principal payments on loan payable	`PaymentsOfLoanCosts`	-	USD	2 Qtrs
Principal payments on loan payable	`PaymentsOfLoanCosts`	$5.00M	USD	2 Qtrs
Principal payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$138.88K	USD	2 Qtrs
Principal payments on capital leases	`RepaymentsOfDebtAndCapitalLeaseObligations`	$108.25K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.54M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.23M	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$12.50M	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.18M	USD	2 Qtrs
Cash Beginning of Period	`CashBeginningOfPeriod`	$1.64M	USD	2 Qtrs
Cash Beginning of Period	`CashBeginningOfPeriod`	$5.55M	USD	2 Qtrs
Cash Ending of Period	`Cash`	$3.37M	USD	Point-in-time
Cash Ending of Period	`Cash`	$1.64M	USD	Point-in-time
Cash Ending of Period	`Cash`	$14.14M	USD	Point-in-time
Cash payments for interest	`InterestPaid`	$26.61K	USD	2 Qtrs
Cash payments for interest	`InterestPaid`	$239.84K	USD	2 Qtrs
Noncash consideration transferred for the acquisition of Healthspan Research LLC	`NoncashConsiderationTransferredForAcquisitionOfHealthspanResearchLlc`	-	USD	2 Qtrs
Noncash consideration transferred for the acquisition of Healthspan Research LLC	`NoncashConsiderationTransferredForAcquisitionOfHealthspanResearchLlc`	$1.19M	USD	2 Qtrs
Capital lease obligation incurred for purchases of equipment	`CapitalLeaseObligationsIncurred`	-	USD	2 Qtrs
Capital lease obligation incurred for purchases of equipment	`CapitalLeaseObligationsIncurred`	$232.11K	USD	2 Qtrs
Inventory supplied to Healthspan Research, LLC for equity interest, at cost	`InventorySuppliedFreeOfChargeToHealthspanResearchLlc`	$20.32K	USD	2 Qtrs
Inventory supplied to Healthspan Research, LLC for equity interest, at cost	`InventorySuppliedFreeOfChargeToHealthspanResearchLlc`	-	USD	2 Qtrs
Retirement of fully depreciated equipment - cost	`PropertyPlantAndEquipmentDisposals`	$28.08K	USD	2 Qtrs
Retirement of fully depreciated equipment - cost	`PropertyPlantAndEquipmentDisposals`	$55.95K	USD	2 Qtrs
Retirement of fully depreciated equipment - accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease`	$-55.95K	USD	2 Qtrs
Retirement of fully depreciated equipment - accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease`	$-28.08K	USD	2 Qtrs

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Offering costs	`PaymentsOfStockIssuanceCosts`	$1.18M	USD	1 Quarter
Beginning Balance, Amount	`StockholdersEquity`	$9.37M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$25.72M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$9.97M	USD	Point-in-time
Issuance of common stock associated with the acquisition of Healthspan Research LLC, Amount	`IssuanceOfCommonStockAssociatedWithAcquisitionOfHealthspanResearchLlcAmount`	$1.00M	USD	1 Quarter
Issuance of common stock, net of offering costs of $1,184,000, Amount	`StockIssuedDuringPeriodValueNewIssues`	$18.71M	USD	1 Quarter
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-3,202.00	shares	2 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.34K	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.62K	USD	1 Quarter
Vested restricted stock, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Vested restricted stock, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$319.83K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$399.86K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$172.96K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-82.67K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.76M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.69M	USD	2 Qtrs
Ending Balance, Amount	`StockholdersEquity`	$9.37M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$25.72M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$9.97M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.